Now the Johns Hopkins University surgeon and researcher has been nominated to lead the Food and Drug Administration. The ...

Palforzia is indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

New research shows home-measured peanut oral immunotherapy boosts peanut tolerance in allergic children, with long-term ...

Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV ...

For children with high-threshold peanut allergy, peanut oral immunotherapy using home-measured peanut butter ingestion yields higher and sustained rates of peanut tolerance.

Discover a proof-of-concept study that was conducted to explore whether dupilumab could induce desensitisation to peanut.

Children with peanut allergy using the Viaskin peanut patch (VP250) may experience greater clinical benefit with long-term use.

We need your help! In the next 24 hours, please ask your House representatives to use the appropriations process to ensure ...

SAN DIEGO -- Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than ...

The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...

SAN DIEGO ‑- Off-the-shelf peanut products used in oral immunotherapy for peanut allergies contain a wide range of protein ...

Almost exactly three years after agreeing on a $2.6 billion deal to acquire Aimmune Therapeutics and its peanut allergy therapy Palforzia, food group Nestle has sold off the business. This morning ...